Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
08.10. | Astellas places $2bn+ bet on AviadoBio dementia gene therapy | ||
08.10. | Setback for J&J's TAR-200 bladder cancer programme | ||
08.10. | AZ and Owkin partner on AI to speed up BRCA testing | ||
08.10. | Scholar Rock preps filings after SMA antibody clears trial | ||
07.10. | MicroRNA pioneers win Nobel Prize for medicine | ||
07.10. | AZ extends cardiovascular pipeline with $2bn CSPC deal | ||
07.10. | NHS England to be given a bigger role in GP data sharing | ||
07.10. | AZ, Avillion's Airsupra aces asthma rescue therapy trial | ||
07.10. | Activist investor Starboard builds $1bn Pfizer stake | ||
07.10. | Mendaera's $73m raise heads digital financings | ||
04.10. | Mounjaro and Zepbound shortages over, declares FDA | ||
04.10. | FDA approval give BMS an edge in NSCLC treatment | ||
03.10. | Gilead strikes deal to expand HIV drug access in 120 countries | ||
03.10. | Research shows NHS, industry partnership benefits patients | ||
03.10. | AI pathology accelerates with Proscia Concentriq launch | ||
02.10. | Revisionist history on healthcare at the VP debate | ||
02.10. | Blue Shield of California bypasses PBMs to slash Humira prices by 90% | ||
02.10. | Amgen to face investor lawsuit over $10.7bn tax liability disclosure | ||
02.10. | FDA issues summary of grants, promotes rare disease research | ||
30.09. | Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy | ||
30.09. | SEC charges Cassava over 'misleading' Alzheimer's claims | ||
27.09. | Sanofi's Dupixent scores double COPD win in US, China | ||
27.09. | Roche's PNH drug PiaSky backed for NHS use by NICE | ||
27.09. | BMS ends decades-long drought in novel schizophrenia drugs | ||
27.09. | World leaders seek 10% cut in antibiotic resistance deaths |